Introducing a noninvasive oral fluid/saliva test kit for SARS-CoV-2 antibodies with qualitative results within 10 to 15 minutes. The CovWipe-19 is manufactured in the U.S and is intended for the qualitative detection of SARS-CoV-2 IgG and IgM in human oral fluid.
CovWipe-19 Oral has been submitted for EUA in early May. The FDA has acknowledged the submissions and is still undergoing review.